ASMB has been in the news 313% more than usual
Dec 28, 2024, 1:31 PM
-2.57%
What does ASMB do
Assembly Biosciences, a biotechnology company based in South San Francisco, develops treatments for chronic hepatitis B and other infectious diseases, with a pipeline including multiple antiviral agents. The company, which went public in December 2010, employs 65 people.
ASMB has been in the news recently: Assembly Biosciences is not mentioned in the provided information. The summary primarily discusses KULR Technology Group's bitcoin acquisition, Governor Hochul's congestion toll and fare increase, political developments in South Korea, and the Climate Change Superfund Act. Therefore, no factual summary can be directly related to Assembly Biosciences or its relevant entities based on the given text.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.